Similarly, although local delivery systems have been reported to release PD-1/PD-L1 inhibitors into the tumor microenvironment directly26,27, they are mainly useful for primary tumors and cannot ensure that PD-1/PD-L1 inhibitors penetrate tumors28. This evidence concerns the gene CD274 and neoplasm.